Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Sort by:
Frontier Pharma: Orphan and Rare Dermatological Diseases – First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa

Published: Sep-2018

Orphan and rare dermatological diseases are considerably diverse in terms of pathophysiology, clinical presentation and.....

$6995
More Info
Global Orphan and Rare Dermatology Drugs Market to 2024 – An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth

Published: Sep-2018

Dermatology is a highly diverse therapy area, in terms of severity and clinical presentation, which deals with diseases.....

$4995
More Info
Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy

Published: Sep-2018

Heart failure (HF) is a life-threatening syndrome with substantial morbidity and mortality. There are more than 26 million.....

$4995
More Info
Blood Pressure Disorders Drug Development Pipeline Review, 2018

Published: Aug-2018

This report provides an overview of the pipeline landscape for blood pressure disorders. It provides comprehensive information.....

$3995
More Info
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

Published: Aug-2018

This report provides an overview of the pipeline landscape for pancreatic and bile duct cancer. It provides comprehensive.....

$3995
More Info
Frontier Pharma: Breast Cancer – First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer

Published: Jul-2018

Breast cancer remains a major global healthcare concern despite exceptional levels of public awareness about the disease......

$6995
More Info
Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 – Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

Published: Jul-2018

Osteoporosis is a “silent epidemic” and as per the WHO declarations, it is a priority health issue. Osteoporosis.....

$4995
More Info
Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline

Published: Jul-2018

Cancer immunotherapy, which can predominantly be classed as a form of targeted therapy, drives an immune response against.....

$4995
More Info
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 – Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

Published: Jul-2018

Colorectal cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally. The five-year.....

$4995
More Info
Diarrhea and Constipation Drug Development Pipeline Review, 2018

Published: Jul-2018

This report provides an overview of the pipeline landscape for diarrhea and constipation. It provides comprehensive information.....

$3995
More Info
Sort by: